Category Archives: Children’s Cancer News

CureSearch Hosts Second Annual Research Symposium!

Topics will focus on emerging themes in laboratory science On October 17-18, CureSearch will host its second annual research symposium in Washington DC. This year’s Symposium, entitled “Translational Oncology: Emerging Targets in Childhood Cancer” will focus on emerging themes in laboratory science with potential for early implementation. Featured speakers include Malcolm Smith, James Bradner, and […]

Update: Researcher to Study Bone Fractures in Pediatric and Adolescent Cancer Survivors

Researchers and physicians know that children who undergo cancer treatment are at risk for decreased bone mineral density because many cancer treatments negatively affect bone health. It is particularly important that children and adolescents develop strong bone density because bone strength decreases in adulthood. Despite this knowledge, little is known about the rate at which […]

Six Young Investigator Grants Now Available!

CureSearch for Children’s Cancer is now accepting applications for six (6) Young Investigator Grants. These “Young Investigator Pathway to Independence Grants” are funded at $225,000 each over three years and are available in the areas of neuroblastoma, palliative care, rhabdomyosarcoma, and three “open” areas. “Open” applications may be in disease or discipline areas of pediatric […]

Clinical Trials Advancement Awards Applications Now Available!

CureSearch is providing up to $1.5 million to support Phase I, Phase II, and Phase III clinical trials taking place at hospitals across the United States which show promise in making a difference for children with cancer, today. Through the Clinical Trials Advancement Awards, funds are available to all qualified hospitals that apply for funding […]

Antipsychotic Drug Fights Cancer

(Oncology Nurse Advisor) – In a prime example of finding new uses for older drugs, studies in zebrafish show that a 50-year-old antipsychotic medication called perphenazine can actively combat the cells of a difficult-to-treat form of acute lymphoblastic leukemia (ALL). The drug works by turning on a cancer-suppressing enzyme called PP2A and causes malignant tumor […]

Childhood Cancer Survivors a Growing Patient Population

But many general practitioners aren’t prepared to deal with them, survey finds HealthDay News- Improved treatment of childhood cancer has led to an unprecedented health care problem, with primary care physicians unprepared to care for the special medical needs of adult cancer survivors, researchers report. A survey of internists — primary care doctors for adults […]

Late effects linked to poor quality of life in long-term childhood cancer survivors

Improved treatments and technologies are leading to more children than ever who survive cancer. Unfortunately, about 70% of these children experience late effects from their disease and treatment 30 years after their cancer diagnosis. These effects significantly impact their quality of life. “The prevalence of these symptoms accounts for a huge variance in physical, mental, […]